Niagen Bioscience, Inc. (NAGE) vs ProQR Therapeutics N.V. (PRQR)
- Niagen Bioscience, Inc. NAGE 2.49 −3.49%
- ProQR Therapeutics N.V. PRQR 1.31 −9.66%
Niagen Bioscience, Inc. and ProQR Therapeutics N.V. are both Biotechnology companies. Niagen Bioscience, Inc. and ProQR Therapeutics N.V. are of similar size ($204.6M and $204.2M). ProQR Therapeutics N.V. has negative trailing earnings, so its P/E is not meaningful; Niagen Bioscience, Inc. trades at 12.5×. ProQR Therapeutics N.V. grew revenue faster over the last twelve months: 19.7% against 11.0%. Niagen Bioscience, Inc. has the higher net margin (12.4% vs −228.7%) and the higher return on invested capital (42.0% vs 0.00%). Across the 17 metrics below, Niagen Bioscience, Inc. leads on 13 and ProQR Therapeutics N.V. on 4.
Valuation
Profitability
| Metric | NAGE | PRQR | Biotechnology median |
|---|---|---|---|
| Gross margin | 64.24% | 100.00% | 65.16% |
| Operating margin | 8.21% | (233.33%) | 0.00% |
| Net margin | 12.39% | (228.71%) | 0.00% |
| Free cash flow margin | 8.89% | (267.36%) | 0.00% |
| Return on equity | 21.80% | (58.29%) | (56.36%) |
| Return on assets | 16.14% | (31.53%) | (48.04%) |
| Return on invested capital | 41.95% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack